126 related articles for article (PubMed ID: 35778691)
1. A population-based validation study of the 8th edition UICC/AJCC TNM staging system for cutaneous melanoma.
Hynes MC; Nguyen P; Groome PA; Asai Y; Mavor ME; Baetz TD; Hanna TP
BMC Cancer; 2022 Jul; 22(1):720. PubMed ID: 35778691
[TBL] [Abstract][Full Text] [Related]
2. A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden.
Isaksson K; Katsarelias D; Mikiver R; Carneiro A; Ny L; Olofsson Bagge R
Ann Surg Oncol; 2019 Sep; 26(9):2839-2845. PubMed ID: 31111349
[TBL] [Abstract][Full Text] [Related]
3. Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma.
Kanaki T; Stang A; Gutzmer R; Zimmer L; Chorti E; Sucker A; Ugurel S; Hadaschik E; Gräger NS; Satzger I; Schadendorf D; Livingstone E
Eur J Cancer; 2019 Sep; 119():18-29. PubMed ID: 31401470
[TBL] [Abstract][Full Text] [Related]
4. How applicable is the TNM 8 staging for human papillomavirus (HPV) related oropharyngeal squamous cell carcinoma (OPSCC) to a UK population of 106 patients? : A cohort comparison of the TNM 7 and TNM8 staging systems for HPV positive oropharyngeal cancer in a UK population.
Bradish T; Fisher H; Paleri V; Robinson M; Meikle D; Kelly C; O'Hara J
Eur Arch Otorhinolaryngol; 2021 Mar; 278(3):755-761. PubMed ID: 32621245
[TBL] [Abstract][Full Text] [Related]
5. Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage.
Teterycz P; Ługowska I; Koseła-Paterczyk H; Rutkowski P
World J Surg Oncol; 2019 Jul; 17(1):129. PubMed ID: 31345228
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the prognostic value of AJCC cancer staging system 7th and 8th editions for differentiated thyroid cancer.
Morosán Allo YJ; Bosio L; Morejón A; Parisi C; Faingold MC; Ilera V; Gauna A; Brenta G
BMC Endocr Disord; 2022 Jun; 22(1):146. PubMed ID: 35650574
[TBL] [Abstract][Full Text] [Related]
7. Prognostic performance of TNM8 staging rules in oral cavity squamous cell carcinoma.
Jawad H; Ashaari SS; O'Shea R; Callanan D; Sheahan P; Feeley L
Oral Oncol; 2020 Dec; 111():105021. PubMed ID: 33011675
[TBL] [Abstract][Full Text] [Related]
8. Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study.
Barreiro-Capurro A; Andrés-Lencina JJ; Podlipnik S; Carrera C; Requena C; Manrique-Silva E; Quaglino P; Tonella L; Jaka A; Richarz N; Rodríguez-Peralto JL; Ortiz P; Boada A; Ribero S; Nagore E; Malvehy J; Puig S
Eur J Cancer; 2021 Mar; 145():29-37. PubMed ID: 33418234
[TBL] [Abstract][Full Text] [Related]
9. Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us?
Zanoni A; Verlato G; Baiocchi GL; Casella F; Cossu A; d'Ignazio A; De Pascale S; Giacopuzzi S
Updates Surg; 2018 Jun; 70(2):241-249. PubMed ID: 29808375
[TBL] [Abstract][Full Text] [Related]
10. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
Yang F; Zhong Q; Huang Z; Lian M; Fang J
Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
[No Abstract] [Full Text] [Related]
11. Comparison of the 7th and 8th Edition of the UICC/AJCC TNM Staging System in Primary Resected Squamous Cell Carcinomas of the Lung-A Single Center Analysis of 354 Cases.
Neppl C; Keller MD; Scherz A; Dorn P; Schmid RA; Zlobec I; Berezowska S
Front Med (Lausanne); 2019; 6():196. PubMed ID: 31552253
[No Abstract] [Full Text] [Related]
12. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.
Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murata N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
J Dermatol Sci; 2019 May; 94(2):284-289. PubMed ID: 31023613
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment.
Koul R; Rathod S; Dubey A; Bashir B; Chowdhury A
Lung Cancer; 2018 Sep; 123():116-120. PubMed ID: 30089581
[TBL] [Abstract][Full Text] [Related]
14. Metrics of pN-staging in oral squamous cell carcinoma: An analysis of 1,905 patients.
Mirian C; Gerds TA; Pedersen MM; de Ridder M; Balm A; Mattavelli D; Piazza C; Jensen LR; Balasubramanian D; Subramaniam N; Dokhe Y; Thankappan K; Iyer S; Karam SD; Wiegand S; Feeley L; Milross C; Gao K; Palme CE; Low TH; Gupta R; Freudlsperger C; Moratin J; Sheahan P; Clark J; Ovesen T
Eur J Cancer; 2021 Jun; 150():33-41. PubMed ID: 33887515
[TBL] [Abstract][Full Text] [Related]
15. Skin melanoma survival is not superior in females in the new stage IIID of the 8th edition of the staging system: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) database.
Mo R; Chen C; Mi L; Ma Z; Tan Q
Ann Transl Med; 2020 Nov; 8(21):1381. PubMed ID: 33313126
[TBL] [Abstract][Full Text] [Related]
16. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
[TBL] [Abstract][Full Text] [Related]
17. External validation of the American Joint Committee on Cancer melanoma staging system eighth edition using the surveillance, epidemiology, and end results program.
Tjokrowidjaja A; Browne L; Soudy H
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e280-e288. PubMed ID: 34811927
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma.
Eggermont AMM; Blank CU; Mandala M; Long GV; Atkinson VG; Dalle S; Haydon A; Lichinitser M; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJ; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; Lupinacci R; Krepler C; Ibrahim N; Kicinski M; Marreaud S; van Akkooi AC; Suciu S; Robert C
Eur J Cancer; 2019 Jul; 116():148-157. PubMed ID: 31200321
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
20. Comparison of long-term prognosis for differentiated thyroid cancer according to the 7th and 8th editions of the AJCC/UICC TNM staging system.
Kim K; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Ther Adv Endocrinol Metab; 2020; 11():2042018820921019. PubMed ID: 32489582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
